Cambridge Nutritional Sciences plc (LON:CNSL – Get Free Report) insider Jeremy Millard acquired 168,776 shares of the company’s stock in a transaction dated Tuesday, November 18th. The stock was acquired at an average cost of GBX 2 per share, with a total value of £3,375.52.
Cambridge Nutritional Sciences Trading Up 11.1%
LON:CNSL opened at GBX 2.50 on Friday. The firm’s fifty day simple moving average is GBX 2.70 and its 200 day simple moving average is GBX 3.07. Cambridge Nutritional Sciences plc has a twelve month low of GBX 1.86 and a twelve month high of GBX 4.38. The firm has a market capitalization of £5.95 million, a price-to-earnings ratio of 3.57 and a beta of 3.89.
Cambridge Nutritional Sciences (LON:CNSL – Get Free Report) last issued its quarterly earnings data on Monday, November 10th. The company reported GBX (0.20) EPS for the quarter. Cambridge Nutritional Sciences had a negative return on equity of 3.34% and a negative net margin of 3.36%. On average, analysts predict that Cambridge Nutritional Sciences plc will post 0.036865 earnings per share for the current year.
About Cambridge Nutritional Sciences
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
Featured Articles
- Five stocks we like better than Cambridge Nutritional Sciences
- What Are Treasury Bonds?
- A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
- What is a SEC Filing?
- 12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming
- The Role Economic Reports Play in a Successful Investment Strategy
- Palo Alto Networks Stock Just Pulled Back—Is This a Prime Buy Zone?
Receive News & Ratings for Cambridge Nutritional Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Nutritional Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
